Canada Prevails In $383M Eli Lilly Case

Law360, New York (March 19, 2017, 9:13 PM EDT) -- Canada has prevailed in a CA$500 million ($383 million) arbitration claim filed by U.S. drugmaker Eli Lilly over the alleged wrongful termination of its drug patents.

The International Centre for the Settlement of Investment Disputes tribunal — composed of presiding arbitrator Albert Jan Van Den Berg, along with Canada appointee Daniel Bethlehem and Eli Lilly appointee Gary B. Born — issued an award on March 16 rejecting Eli Lilly's claims, which had been filed under the North American Free Trade Agreement.

ICSID posted a copy of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.